Volume 73, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


We assessed the efficacy of trimethoprim/sulfamethoxazole (TRM/SMX) in relation to the frequency of dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) alleles in 45 Sudanese malaria patients. Plasma levels of TRM, SMX, and acetylsulfamethoxazole (AcSMX) were measured before treatment and at days 3, 7, and 14 or upon recrudescence to ascertain drug absorption. Forty patients (89%) had an adequate clinical response, one patient (2%) had an early treatment failure response, while four patients (8%) showed late treatment failure responses. Genotyping of merozoite surface protein 1, MSP-1, MSP-2, and glutamate-rich protein before treatment and upon recrudescence showed that all recurring parasites were recrudescences. The plasma levels of TRM, AcSMX, and SMX indicated adequate drug absorption in all patients. This suggests parasite resistance as a cause of treatment failure. The presence of dhfr Ile 51 and Asn 108 alone or coupled with dhps Ala-436 among parasites that were cleared after treatment indicates that these alleles alone are insufficient to cause resistance. However, the presence of the triple mutant dhfr (Ile-51/Arg-59/Asn-108) with the dhps Gly-437 genotype in all recurring infections, suggests the importance of codon 59 and 437 alleles in susceptibility to TRM/SMX. However, the number is too little to make firm conclusions.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Iyer JK, Milhous WK, Cortese JF, Kublin JG, Plowe CV, 2001. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 29 : 1066–1067. [Google Scholar]
  2. Jelinek T, Kilian A, Curtis J, Duraisingh M, Kabagambe G, Warhurst DP, 1999. Plasmodium falciparum: selection for Ser 108 of DHFR during treatment of uncomplicated malaria with cotrimoxazole in Ugandan children. Am J Trop Med Hyg 61 : 125–130. [Google Scholar]
  3. World Health Organization, 1996. Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Geneva: World Health Organization. WHO/MAL/96.1077.
  4. Khalil IF, Alifrangis M, Ronn AM, Gabar HA, Jelinek T, Satti GM, Bygbjerg IC, 2002. Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome. Am J Trop Med Hyg 67 : 225–229. [Google Scholar]
  5. Snounou G, Beck H, 1998. The use of PCR genotyping in the assessment of recrudescence or re-infection after antimalarial treatment. Parasitol Today 14 : 462–467. [Google Scholar]
  6. Rønn AM, Mutabingwa T, Kreisby S, Angelo HM, Fuursted K, Bygbjerg IC, 1999. A reversed phase high-pressure liquid chromatography method for the determination of cotrimoxazole (TRM/SMX) in children treated for malaria. Ther Drug Monit 21 : 609–614. [Google Scholar]
  7. Djimde A, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV, 2003. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg 69 : 558–563. [Google Scholar]
  8. Wang P, Shinn O, Bayoumi R, Djimde A, Doumbo O, Swedbrg G, Daol L, Mshinda H, Hyde JE, 1997. Resistance to the antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthase and dihydrofolate reductase alleles in a large number of field samples of diverse origin. Mol Biochem Parasitol 89 : 161–177. [Google Scholar]
  9. Warhurst D, 2002. Resistance to antifolates in P. falciparum, the causative agent of tropical malaria. Sci Prog 85 : 89–111. [Google Scholar]
  10. Plowe C, Cortese J, Djimde A, Nwanyanwu O, Watkins W, Winstanley P, Estrada-Franco J, Mollinedo R, Avila J, Cespedes J, Carter D, Doumbo O, 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176 : 1590–1596. [Google Scholar]
  11. Kilian AH, Jelinek T, Prislin I, Kabagambe G, Byamukama W, Mpigika G, Korte R, von Sonnenburg F, 1998. Resistance in vivo of P. falciparum to cotrimoxazole in western Uganda. Trans R Soc Trop Med Hyg 92 : 197–200. [Google Scholar]
  12. Reeves D, Wilkinson P, 1979. The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues. Infection 7 (Supp 4): S330–S341. [Google Scholar]
  13. Hansford C, Hoyland J, 1982. An evaluation of cotrimoxazole in the treatment of P. falciparum malaria. S Afr Med J 61 : 512–514. [Google Scholar]

Data & Media loading...

  • Received : 14 Jul 2004
  • Accepted : 02 Feb 2005

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error